IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712 (Source: Cell Research)
Source: Cell Research - April 1, 2024 Category: Cytology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712 (Source: Oncology Research)
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research
GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis
Oncol Res. 2024 Mar 20;32(4):727-736. doi: 10.32604/or.2023.043391. eCollection 2024.ABSTRACTPrimary tumors of the central nervous system (CNS) are classified into over 100 different histological types. The most common type of glioma is derived from astrocytes, and the most invasive glioblastoma (WHO IV) accounts for over 57% of these tumors. Glioblastoma (GBM) is the most common and fatal tumor of the CNS, with strong growth and invasion capabilities, which makes complete surgical resection almost impossible. Despite various treatment methods such as surgery, radiotherapy, and chemotherapy, glioma is still an incurable di...
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Guoqiang Hou Xinhang Xu Weixing Hu Source Type: research
Solid CaCO3 Formation in Glioblastoma Multiforme and its Treatment with Ultra-Nanoparticulated NPt-Bionanocatalysts
CONCLUSION: Bionanocatalysts demonstrate promise as a viable treatment option for severe cases of GBM. Additionally, the identification of solid calcium carbonate formations may serve as a diagnostic marker not only for GBM but also for other CNS pathologies.PMID:38561623 | DOI:10.2174/0115680096289012240311023133 (Source: Current Cancer Drug Targets)
Source: Current Cancer Drug Targets - April 1, 2024 Category: Cancer & Oncology Authors: Tessy L ópez-Goerne Alfonso Arellano Francisco J Padilla-God ínez Carlos Maga ña Antonela Gonz ález-Bondani Rafael Valiente Source Type: research
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712 (Source: Oncology Research)
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research
GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis
Oncol Res. 2024 Mar 20;32(4):727-736. doi: 10.32604/or.2023.043391. eCollection 2024.ABSTRACTPrimary tumors of the central nervous system (CNS) are classified into over 100 different histological types. The most common type of glioma is derived from astrocytes, and the most invasive glioblastoma (WHO IV) accounts for over 57% of these tumors. Glioblastoma (GBM) is the most common and fatal tumor of the CNS, with strong growth and invasion capabilities, which makes complete surgical resection almost impossible. Despite various treatment methods such as surgery, radiotherapy, and chemotherapy, glioma is still an incurable di...
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Guoqiang Hou Xinhang Xu Weixing Hu Source Type: research
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712 (Source: Oncology Research)
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research
GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis
Oncol Res. 2024 Mar 20;32(4):727-736. doi: 10.32604/or.2023.043391. eCollection 2024.ABSTRACTPrimary tumors of the central nervous system (CNS) are classified into over 100 different histological types. The most common type of glioma is derived from astrocytes, and the most invasive glioblastoma (WHO IV) accounts for over 57% of these tumors. Glioblastoma (GBM) is the most common and fatal tumor of the CNS, with strong growth and invasion capabilities, which makes complete surgical resection almost impossible. Despite various treatment methods such as surgery, radiotherapy, and chemotherapy, glioma is still an incurable di...
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Guoqiang Hou Xinhang Xu Weixing Hu Source Type: research
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712 (Source: Oncology Research)
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research
GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis
Oncol Res. 2024 Mar 20;32(4):727-736. doi: 10.32604/or.2023.043391. eCollection 2024.ABSTRACTPrimary tumors of the central nervous system (CNS) are classified into over 100 different histological types. The most common type of glioma is derived from astrocytes, and the most invasive glioblastoma (WHO IV) accounts for over 57% of these tumors. Glioblastoma (GBM) is the most common and fatal tumor of the CNS, with strong growth and invasion capabilities, which makes complete surgical resection almost impossible. Despite various treatment methods such as surgery, radiotherapy, and chemotherapy, glioma is still an incurable di...
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Guoqiang Hou Xinhang Xu Weixing Hu Source Type: research
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712 (Source: Oncology Research)
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research
GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis
Oncol Res. 2024 Mar 20;32(4):727-736. doi: 10.32604/or.2023.043391. eCollection 2024.ABSTRACTPrimary tumors of the central nervous system (CNS) are classified into over 100 different histological types. The most common type of glioma is derived from astrocytes, and the most invasive glioblastoma (WHO IV) accounts for over 57% of these tumors. Glioblastoma (GBM) is the most common and fatal tumor of the CNS, with strong growth and invasion capabilities, which makes complete surgical resection almost impossible. Despite various treatment methods such as surgery, radiotherapy, and chemotherapy, glioma is still an incurable di...
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Guoqiang Hou Xinhang Xu Weixing Hu Source Type: research
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712 (Source: Oncology Research)
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research
GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis
Oncol Res. 2024 Mar 20;32(4):727-736. doi: 10.32604/or.2023.043391. eCollection 2024.ABSTRACTPrimary tumors of the central nervous system (CNS) are classified into over 100 different histological types. The most common type of glioma is derived from astrocytes, and the most invasive glioblastoma (WHO IV) accounts for over 57% of these tumors. Glioblastoma (GBM) is the most common and fatal tumor of the CNS, with strong growth and invasion capabilities, which makes complete surgical resection almost impossible. Despite various treatment methods such as surgery, radiotherapy, and chemotherapy, glioma is still an incurable di...
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Guoqiang Hou Xinhang Xu Weixing Hu Source Type: research
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712 (Source: Oncology Research)
Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research
